Back
ProShares UltraPro MidCap400 Vs. Keros Therapeutics Industry Stock Comparison
Buy
51
UMDD
ProShares UltraPro MidCap400
Last Price:
23.86
Seasonality Move:
1.02%
Sell
27
KROS
Keros Therapeutics
Last Price:
45.71
Seasonality Move:
4.22%
Buy
51
ProShares UltraPro MidCap400 (UMDD)
is a Buy
Is ProShares UltraPro MidCap400 a Buy, Sell or Hold?
- The current ProShares UltraPro MidCap400 [UMDD] share price is $24.10. The Score for UMDD is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- UMDD is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
27
Keros Therapeutics (KROS)
is a Sell
Is Keros Therapeutics a Buy, Sell or Hold?
- The current Keros Therapeutics [KROS] share price is $45.70. The Score for KROS is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- KROS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
UMDD Stock Price Chart
What is ProShares UltraPro MidCap400's stock price today?
-
The ProShares UltraPro MidCap400 share price today is $24.10
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and UMDD is experiencing slight selling pressure.
KROS Stock Price Chart
What is Keros Therapeutics's stock price today?
-
The Keros Therapeutics share price today is $45.70
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing slight buying pressure.
UMDD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.31 | Sell |
| Relative Strength Index (14 RSI): | 46.4 | Sell |
| Chaikin Money Flow: | -5484 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (23.91 - 25.09) | Sell |
| Bollinger Bands (100): | (23.24 - 26.4) | Sell |
KROS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.79 | Sell |
| Relative Strength Index (14 RSI): | 38.41 | Sell |
| Chaikin Money Flow: | 239305 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (45.72 - 49.1) | Sell |
| Bollinger Bands (100): | (49.87 - 64.91) | Sell |
UMDD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.15 | Sell |
| 20-day SMA: | 24.37 | Sell |
| 50-day SMA: | 24.79 | Sell |
| 200-day SMA: | 21.62 | Buy |
| 8-day EMA: | 24.12 | Sell |
| 20-day EMA: | 24.4 | Sell |
| 50-day EMA: | 24.68 | Sell |
| 200-day EMA: | 22.81 | Buy |
KROS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 45.61 | Buy |
| 20-day SMA: | 47.29 | Sell |
| 50-day SMA: | 51.65 | Sell |
| 200-day SMA: | 47.07 | Sell |
| 8-day EMA: | 45.93 | Sell |
| 20-day EMA: | 47.34 | Sell |
| 50-day EMA: | 50.89 | Sell |
| 200-day EMA: | 50 | Sell |
ProShares UltraPro MidCap400 Earnings Growth & UMDD Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Keros Therapeutics Earnings Growth & KROS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.03 per share, an increase this year of $0.35 per share, and a decrease next year of $0.39 per share.
ProShares UltraPro MidCap400 Technical Analysis
| Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Keros Therapeutics Technical Analysis
| Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||